Section 1: National Cancer Institute

The constituent agreement of the National Cancer Institute is approved by order of the ministers responsible for the budget, research and health. In particular, it sets out the extent of the powers exercised by the Chairman of the Board of Directors and the Chief Executive Officer. The constituent agreement may stipulate that the Chairman of the Board of Directors shall execute and implement the decisions of the General Meeting and…

The Institute has legal personality from the date of publication in the Journal officiel of the approval order provided for in article D. 1415-1-1, accompanied by extracts from the constituent agreement. The publication mentions in particular: 1° The purpose of the group constituting the institute ; 2° The identity of its members ; 3° The registered office ; 4° The rules governing the liability of members towards each other and…

The Chairman of the Institute’s Board of Directors is appointed on the advice of the Board.

The term of office for members of the Institute’s Board of Directors and Scientific Council is five years, renewable, with the exception of Members of Parliament whose term of office expires with the legislature for which they were elected and Senators whose term of office expires with each partial renewal of the Senate. The terms of office of the Chairman of the Board of Directors and the Chairman of the…

The Institute has the capacity to borrow from financial institutions. All loans are subject to the approval of the ministers responsible for the budget, research and health.

The Institute’s accounts are kept in accordance with the provisions of Titles I and III of Decree no. 2012-1246 of 7 November 2012 on public budgetary and accounting management, with the exception of Articles 220 to 228. The accounting officer is appointed by an order of the Minister in charge of the budget, after approval by the Chairman of the Institute’s Board of Directors.

As part of its mission to coordinate the cancer control initiatives mentioned in Article L. 1415-2, the Institute : 1° Rely, where necessary, on the one hand on the professionals, health industry professionals and user representatives mentioned in article L. 1415-2, and on the other hand on the central government administrations, its decentralised departments, its departments with national competence and its public establishments, in particular the regional health agencies; 2°…

The criteria for approval of the health establishments mentioned in 2° of Article L. 1415-2 are defined by decision of the Institute’s Board of Directors.

The eight-year period referred to in Article L. 1415-7 corresponds to the maximum period of funding for a research project under a grant awarding act, when the clinical or fundamental research project cannot be completed in five years due to its particular complexity. The projects mentioned in the first paragraph may benefit from this time period by decision of the President of the Institut National du Cancer, taken after obtaining…